Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir

Acta Virol. 2013;57(3):375-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / administration & dosage
  • Acyclovir / analogs & derivatives*
  • Adult
  • Allografts / drug effects
  • Allografts / virology
  • Antiviral Agents / administration & dosage*
  • Cytomegalovirus / drug effects
  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections / etiology
  • Cytomegalovirus Infections / prevention & control*
  • Cytomegalovirus Infections / virology
  • Female
  • Ganciclovir / administration & dosage*
  • Humans
  • Kidney Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control*
  • Postoperative Complications / virology
  • Valacyclovir
  • Valine / administration & dosage
  • Valine / analogs & derivatives*

Substances

  • Antiviral Agents
  • Valine
  • Valacyclovir
  • Ganciclovir
  • Acyclovir